Exodus Point Capital Management, LP Axsome Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 29,479 shares of AXSM stock, worth $2.64 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,479Holding current value
$2.64 Million% of portfolio
0.02%Shares
10 transactions
Others Institutions Holding AXSM
# of Institutions
326Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$376 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$296 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$212 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$93.8 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.85B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...